ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 253 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,036 | -41.1% | 27,400 | -43.5% | 0.00% | -33.3% |
| Q2 2023 | $611,100 | -42.5% | 48,500 | -40.4% | 0.01% | -45.5% |
| Q1 2023 | $1,062,270 | -44.0% | 81,400 | -24.3% | 0.01% | -45.0% |
| Q4 2022 | $1,896,300 | +144.1% | 107,500 | +110.8% | 0.02% | +122.2% |
| Q3 2022 | $776,730 | -31.7% | 51,000 | +1.0% | 0.01% | -18.2% |
| Q1 2022 | $1,137,000 | -34.6% | 50,500 | -46.4% | 0.01% | -8.3% |
| Q4 2021 | $1,738,000 | -21.5% | 94,200 | -43.2% | 0.01% | -47.8% |
| Q3 2021 | $2,215,000 | +75.5% | 165,700 | +143.0% | 0.02% | +91.7% |
| Q2 2021 | $1,262,000 | +210.1% | 68,200 | +151.7% | 0.01% | +200.0% |
| Q1 2021 | $407,000 | -50.9% | 27,100 | -77.0% | 0.00% | -63.6% |
| Q1 2020 | $829,000 | -4.2% | 117,700 | +33.6% | 0.01% | +22.2% |
| Q4 2019 | $865,000 | +84.8% | 88,100 | +140.1% | 0.01% | +50.0% |
| Q2 2017 | $468,000 | +17.3% | 36,700 | +9.9% | 0.01% | 0.0% |
| Q1 2015 | $399,000 | – | 33,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |